Literature DB >> 20298208

Presynaptic dysfunction in Huntington's disease.

José L Rozas1, Leonardo Gómez-Sánchez, Cristina Tomás-Zapico, José J Lucas, Rafael Fernández-Chacón.   

Abstract

HD (Huntington's disease) is produced by the expression of mutant forms of the protein htt (huntingtin) containing a pathologically expanded poly-glutamine repeat. For unknown reasons, in HD patients and HD mouse models, neurons from the striatum and cerebral cortex degenerate and lead to motor dysfunction and dementia. Synaptic transmission in those neurons becomes progressively altered during the course of the disease. However, the relationship between synaptic dysfunction and neurodegeneration in HD is not yet clear. Are there early specific functional synaptic changes preceding symptoms and neurodegeneration? What is the role of those changes in neuronal damage? Recent experiments in a Drosophila model of HD have showed that abnormally increased neurotransmitter release might be a leading cause of neurodegeneration. In the present review, we summarize recently described synaptic alterations in HD animal models and discuss potential underlying molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20298208     DOI: 10.1042/BST0380488

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  14 in total

1.  Tonic mGluR5/CB1-dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin.

Authors:  Anton Dvorzhak; Marcus Semtner; Donald S Faber; Rosemarie Grantyn
Journal:  J Physiol       Date:  2012-12-10       Impact factor: 5.182

2.  Cdk5 Contributes to Huntington's Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.

Authors:  Elena Alvarez-Periel; Mar Puigdellívol; Verónica Brito; Florian Plattner; James A Bibb; Jordi Alberch; Silvia Ginés
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

3.  The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology.

Authors:  Joost Schulte; J Troy Littleton
Journal:  Curr Trends Neurol       Date:  2011-01-01

Review 4.  Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.

Authors:  P Hemachandra Reddy; Ulziibat P Shirendeb
Journal:  Biochim Biophys Acta       Date:  2011-11-04

Review 5.  Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.

Authors:  Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590

6.  Striatal network modeling in Huntington's Disease.

Authors:  Adam Ponzi; Scott J Barton; Kendra D Bunner; Claudia Rangel-Barajas; Emily S Zhang; Benjamin R Miller; George V Rebec; James Kozloski
Journal:  PLoS Comput Biol       Date:  2020-04-17       Impact factor: 4.475

7.  Striatal synaptosomes from Hdh140Q/140Q knock-in mice have altered protein levels, novel sites of methionine oxidation, and excess glutamate release after stimulation.

Authors:  Antonio Valencia; Ellen Sapp; Jeffrey S Kimm; Hollis McClory; Kwadwo A Ansong; George Yohrling; Seung Kwak; Kimberly B Kegel; Karin M Green; Scott A Shaffer; Neil Aronin; Marian DiFiglia
Journal:  J Huntingtons Dis       Date:  2013

8.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

9.  Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts.

Authors:  Fiorella Malchiodi-Albedi; Silvia Paradisi; Andrea Matteucci; Claudio Frank; Marco Diociaiuti
Journal:  Int J Alzheimers Dis       Date:  2011-02-08

10.  A system for performing high throughput assays of synaptic function.

Authors:  Chris M Hempel; Michael Sivula; Jonathan M Levenson; David M Rose; Bing Li; Ana C Sirianni; Eva Xia; Timothy A Ryan; David J Gerber; Jeffrey R Cottrell
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.